Rigel Pharmaceuticals, Inc. RIGL
39.65 USD -6.06 (-13.26%)
At closeNov 6, 2026, 4:00 PM EST
39.65 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
37.60 Day range 41.67
25.44 52-week range 51.45
- YTD
- -7.42%
- 1 year
- +9.77%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 294.28M | 179.28M | 116.88M | 120.24M | 149.24M | |
| 294.28M | 179.28M | 116.88M | 120.24M | 149.24M | |
| 19.62M | 18.65M | 7.11M | 1.75M | 1.08M | |
| 274.66M | 160.63M | 109.77M | 118.49M | 148.15M | |
| 149.19M | 136.44M | 130.26M | 174.04M | 160.65M | |
| 33.30M | 23.38M | 24.52M | 60.27M | 65.24M | |
| 115.90M | 113.06M | 105.74M | 112.45M | 91.89M | |
| 125.47M | 24.19M | -20.49M | -55.55M | -12.50M | |
| 7.32M | 7.92M | 6.87M | 3.71M | 4.86M | |
| -245.20M | 881.00K | 0 | 0 | 605.00K | |
| 367.02M | 17.48M | -25.09M | -58.57M | -17.91M | |
| 367.02M | 17.48M | -25.09M | -58.57M | -17.91M | |
| 367.02M | 17.48M | -25.09M | -58.57M | -17.91M | |
| 367.02M | 17.48M | -25.09M | -58.57M | -17.91M | |
| 20.40 | 0.99 | -1.44 | -3.44 | -1.10 | |
| 20.40 | 0.99 | -1.44 | -3.44 | -1.10 | |
| 19.48 | 0.99 | -1.44 | -3.44 | -1.10 | |
| 129.15M | 26.28M | -18.22M | -54.87M | -12.45M | |
| 129.15M | 26.28M | -18.22M | -54.87M | -12.45M | |
| 17.99M | 17.58M | 17.40M | 17.05M | 17.05M | |
| 18.84M | 17.69M | 17.40M | 17.05M | 17.05M |
